Otto Scheiner

Title: Innovations of Otto Scheiner in Cancer Vaccines

Introduction

Otto Scheiner is a notable inventor based in Mariaenzersdorf, Austria. He has made significant contributions to the field of cancer research, particularly in the development of vaccines targeting cancerous diseases. With a total of 7 patents, his work has the potential to impact cancer treatment and diagnostics significantly.

Latest Patents

One of his latest patents focuses on a vaccine against cancer diseases associated with the HER-2/neu oncogene. This invention involves peptides from the extracellular domain of the HER-2/neu protein, which are linked to an immunogenic carrier. The patent also covers diagnostic methods for detecting cancerous conditions related to HER-2/neu and methods to enhance immune responses in patients. Another significant patent involves a vaccine based on mimotopes of antigens expressed on tumor cells. This method utilizes antibodies to select mimotopes from a phage peptide library, which are then conjugated to a macromolecular carrier. The resulting vaccine aims to elicit a humoral immune response, leading to active immunity against cancer.

Career Highlights

Throughout his career, Otto Scheiner has worked with various organizations, including Biomay Produktions- und Handelsgesellschaft M.b.h. His innovative approaches to vaccine development have positioned him as a key figure in cancer research.

Collaborations

He has collaborated with notable individuals in the field, including Heimo Breiteneder and Rudolf Valenta. Their combined expertise has contributed to the advancement of cancer treatment methodologies.

Conclusion

Otto Scheiner's work in developing cancer vaccines showcases his dedication to improving patient outcomes through innovative research. His patents reflect a commitment to advancing medical science and providing new avenues for cancer treatment.